As of July 2026, AXON's current EPS stands at $2.57, according to the latest financial reports. For the year 2025, the company recorded an earnings per share (EPS) of $1.6, which marks a drop compared to its EPS of $4.98 in 2024. AXON reported an EPS of $2.11 for the quarterly report ending on Mar 31, 2026.
For 2025, Axon Enterprise's EPS was $1.6, a drop of 67.9% from $4.98 in 2024. For the fiscal quarter that ended on Mar 31, 2026, the per-share earnings was $2.11, showing a 85.1% increase from the same quarter last year. For the twelve months ending March 2026, the EPS is $2.57. For the year 2024, the yearly earnings per share was $4.98, marking an increase of 110.1% from 2023.
Axon Enterprise has registered an increase in EPS of 85.1% during the last 12 months (YoY, quarterly). In the last three years, AXON recorded an average annual EPS growth rate of -8.2%. Across the last decade, AXON had an average annual EPS growth of 15.8%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| EXEL Exelixis Inc | 17.96 | 60% | 71.6% | 51.6% |
| AXON Axon Enterprise Inc | 212.85 | -67.9% | -8.2% | N/A |
| XBIT XBiotech Inc | N/A | -18.3% | N/A | N/A |
| QURE uniQure NV | N/A | 29.7% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.